Posted by Michael Wonder on 13 Mar 2019
Senate panel asks CVS and four other pharmacy middlemen to testify about drug prices
12 March 2019 - The Senate Finance Committee invited five major pharmacy benefit managers to testify on April 3.
The Senate Finance Committee said Tuesday it invited five major pharmacy benefit managers to testify before Congress about high prescription drug costs in the U.S.
Chairman Chuck Grassley, R-Iowa., and Ron Wyden, D-Ore., the committee’s ranking member, asked Cigna, CVS, Humana, OptumRx and Prime Therapeutics to testify on Capitol Hill on April 3. Both senators have been critical of PBMs, sometimes referred to as middlemen, which negotiate drug benefits with manufacturers for insurance plans and employers.
